Cell therapy constitutes an important methodology for the treatment of many incurable diseases. Cellider Biotech wants to provide researchers with the possibility to choose an adequate cellular source for each experiment, offering a variety of primary cells, stem cells, and blood cells.

Recently, regenerative medicine has emerged as an important field, showing therapeutic potential of adult stem cells in medicine. As part of regenerative medicine, tissue engineering can be used to generate tissues in vitro to repair damaged tissues. Development of successful engineered tissues is dependent on choosing the ideal cell source for the tissue, and adult stem cells have been shown as a highly favorable candidate. Stem cells have some characteristics that distinguish them from other cell types: they have the potential for self-renewal, they can be induced to differentiate in different cell types, and they can be implanted in healthy and damaged tissues. Mesenchymal stem cells from different tissues (i.e. bone marrow, adipose tissue, umbilical cord blood, etc.) are promising cell types in regenerative medicine, due to their ability to differentiate into several cell lineages and their immunomodulatory properties. On the other hand, blood-derived cells are a very useful for the studying the immune response, autoimmune diseases, and some forms of cancer.

Adipose stem cells Dental pulp stem cells Bone marrow stem cells (Coming soon)

Chondrocytes Fibroblasts  

Peripheral blood mononuclear cells

Cellider Biotech

Avda. San Juan Bosco, 13
50009 Zaragoza (Spain)

Phone: +34 876 041 397
This email address is being protected from spambots. You need JavaScript enabled to view it.

Connect with us



Avda. San Juan Bosco, 13. 50009 Zaragoza (Spain)

Tel: +34 876 041 397, Mail:

Avda. San Juan Bosco, 13. 50009 Zaragoza (Spain)

Tel: +34 876 041 397, Mail: